Stay updated on Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T01:36:32.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:06:43.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The study record page displays a 403 Forbidden message and a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-04T01:52:17.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, with a minimal navigation header indicating an access issue. This reflects restricted access rather than a content update.
    Difference
    18%
    Check dated 2026-09-20T00:47:52.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    An NIH grant/contract attribution for 2015 was added, and the page revision text was updated from v3.6.5 to v3.6.6, reflecting a minor version update in the page’s metadata.
    Difference
    0.1%
    Check dated 2026-08-29T21:48:34.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page's revision tag updated from v3.6.4 to v3.6.5, indicating a new version of the page.
    Difference
    0.1%
    Check dated 2026-08-08T23:18:12.000Z thumbnail image

Stay in the know with updates to Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Pexidartinib in Pancreatic/Colorectal Clinical Trial page.